Skip to content
FTHFTH
Head & Neck Cancer · 頭頸部がん

Head and Neck Cancer

Insurance-covered

Basic Information

Fractions
Head and neck tumors and lacrimal gland cancer (excluding squamous cell carcinoma of the oral cavity, pharynx, and larynx): 16 fractions, 4 weeks
Description
Insurance covers non-squamous cell carcinomas such as salivary gland cancer, mucosal malignant melanoma, squamous cell carcinoma outside the oral cavity, pharynx, and larynx, and head and neck sarcomas. Squamous cell carcinomas of the oral cavity, pharynx, and larynx respond well to conventional radiotherapy and are excluded; cases with distant metastasis are generally not eligible.
Source: QST Hospital 「重粒子線治療の適応」 — View original ↗

Related Articles

1articles
2026.10.11

Carbon Ion Therapy for Head and Neck Cancer: Target Diseases, 16-Fraction Schedule, and Side Effects (Summary of QST Hospital Physicians’ Materials)

Head and neck cancer and carbon ion therapy

The head and neck brings together functions such as speaking, swallowing, and breathing, so radiotherapy that preserves function plays a large role. Squamous cell carcinoma, about 90% of head and neck cancers, responds relatively well to X-ray therapy and chemotherapy. The remaining 10%, non-squamous cell carcinomas, are often resistant to X-rays and rare, so treatment development has been slow. QST Hospital has focused carbon ion therapy on such X-ray-resistant head and neck cancers.

Learn More
← PreviousSkull Base TumorsFull listNext →Eye Tumors